Javelin Minerals Limited (JAV.AX)
AUD 0.0
(0.0%)
AUD 0.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | 1335.00 | 3278.00 |
| Gross Profit | - | - | - | - | -1335.00 | -3278.00 |
| Operating Expenses | 921.2 Thousand | 680.42 Thousand | 987.51 Thousand | 666.59 Thousand | 475.91 Thousand | 12.99 Million |
| Selling, General and Administrative Expenses | 921.2 Thousand | 348.83 Thousand | 274.78 Thousand | 345.22 Thousand | 116.54 Thousand | 375.65 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | 20 Thousand | - | - |
| Cost and Expenses | 921.2 Thousand | 680.42 Thousand | 987.51 Thousand | 666.59 Thousand | 475.91 Thousand | 12.99 Million |
| Operating Income | -921.2 Thousand | -680.42 Thousand | -987.51 Thousand | -666.59 Thousand | -475.91 Thousand | -12.99 Million |
| Interest Expense | - | - | - | - | - | 98.08 Thousand |
| Income Tax Expense | - | -23.69 | -315.47 | -6773.84 | -204.96 Thousand | -168.58 Thousand |
| Earnings before Tax | -3.79 Million | -660.09 Thousand | -976.63 Thousand | -639.97 Thousand | -471.21 Thousand | -13.09 Million |
| Net Income | -3.79 Million | -660.09 Thousand | -976.63 Thousand | -639.97 Thousand | -471.21 Thousand | -13.09 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.05 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.05 |
| Weighted Average Shares Outstanding | 1.51 Billion | 1.4 Billion | 1.16 Billion | 710.28 Million | 379.53 Million | 243.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.51 Billion | 1.4 Billion | 1.16 Billion | 710.28 Million | 379.53 Million | 243.28 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -921.12 Thousand | -660.09 Thousand | -672.04 Thousand | -483.75 Thousand | -469.87 Thousand | -13.08 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 193.82 | 193.82 | 266.78 | 278.09 | 274.33 Thousand | 680.42 Thousand |
| Selling, General and Administrative Expenses | 193.82 | 193.82 | 266.78 | 266.78 | 274.33 Thousand | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 193.82 | 193.82 | 266.78 | 278.09 | 274.33 Thousand | 680.42 Thousand |
| Operating Income | -193.82 | -193.82 | -266.78 | -278.09 | -274.33 Thousand | -680.42 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -1427.66 | -1427.66 | -11.31 | - | -9.00 | -23.69 |
| Earnings before Tax | -1619.41 | -1619.41 | -276.84 | -276.84 | -289.41 Thousand | -660.09 Thousand |
| Net Income | -1619.41 | -1619.41 | -276.84 | -276.84 | -289.41 Thousand | -660.09 Thousand |
| Earnings Per Share Basic | - | -0.00 | -0.00 | -0.00 | -0.00 | - |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | -0.00 | -0.00 | - |
| Weighted Average Shares Outstanding | 2.01 Billion | 2.01 Billion | 1.02 Billion | 1.02 Billion | 1.41 Billion | 1.4 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.01 Billion | 2.01 Billion | 1.02 Billion | 1.02 Billion | 1.41 Billion | 1.4 Billion |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -193.78 | -193.78 | -266.78 | -266.78 | -274.33 Thousand | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
7971
4599
PKBFF
HEALTHYLIFE
7897
IXOG